Skip navigation
Sitemap
Menu
Search

Paul D. Savage, MD

  • Medical Oncology and Hematology
Contact
See More Locations
Wake Forest Baptist Provider
Treats only Adults
AboutConditions & TreatmentsLocationsCredentialsResearch InterestsBack to TopPublications

About

Practicing Specialties

Medical Oncology and Hematology

Languages

EnglishHebrew

Conditions and Treatments

Adrenal CancerBone CancerBone TumorCardiac SarcomaChemotherapyChondrosarcomaEndocrine TumorsEwing's SarcomaFibrosarcomaMediastinal DiseasesMelanomaMerkel Cell CarcinomaMesotheliomaMultiple Endocrine Neoplasia Type 2 (MEN 2)Neuroendocrine Cancer and TumorsParathyroid CancerPrecision MedicineSarcomaSarcomas of the Chest WallSebaceous CarcinomaSkin CancerSoft Tissue TumorSquamous Cell CarcinomaThymoma and Thymic CancerThyroid Cancer

Ratings and Reviews

Locations

Credentials

Board Certifications

American Board of Internal Medicine

Memberships

Connective Tissue Oncology Society, 2013American College of Physicians, 2013American Society of Clinical Oncology, 2013American Association for Cancer Research, 2013American Society of Hematology, 2013

Positions

Hematology and Oncology, Associate Professor

Research Interests

MelanomasMolecular GeneticsMolecular OncologyNovel DrugsRare CancersSarcomas

Publications

Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma.

Savage PD, Lovato J, Brosnihan KB, Miller AA, Petty WJ. . 2016; 2016:4592768.

Reverse translation of phase I biomarker findings links the activity of angiotensin-(1-7) to repression of hypoxia inducible factor-1a in vascular sarcomas.

Petty WJ, Aklilu M, Varela VA, Lovato J, Savage PD, Miller AA. BMC Cancer. 2012 Sep; 12:404.

Phase I study of lenalidomide in solid tumors.

Miller AA, Case D, Harmon M, Savage P, Lesser G, Hurd D, Melin SA. J Thorac Oncol. 2007 May; 2(5):445-9.

Inflammatory myofibroblastic tumor with bone marrow involvement. A case report and review of the literature.

Hagenstad CT, Kilpatrick SE, Pettenati MJ, Savage PD. Arch Pathol Lab Med. 2003 Jul; 127(7):865-7.

Cystic changes in hepatic metastases from gastrointestinal stromal tumors (GISTs) treated with Gleevec (imatinib mesylate).

Chen MY, Bechtold RE, Savage PD. AJR Am J Roentgenol. 2002 Oct; 179(4):1059-62.